A. In this chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) “Accredited educational program” means a program accredited by The Commission on Accreditation of Allied Health Education Programs (CAAHEP), or its successor accrediting agency.
(2) “Board” means the State Board of Physicians.
(3) “Certified clinical perfusionist” means an individual holding a certificate issued by the national certifying board.
(4) “Certification” means recognition of an individual who has satisfied certain standards required by the national certifying board.
(5) “Committee” means the Perfusion Advisory Committee established under Health Occupations Article, §14-5E-05, Annotated Code of Maryland.
(6) “Conversion” means changing a license from licensed perfusionist-basic to licensed perfusionist-advanced.
(7) “Immediately available direction” means the responsibility of a licensed physician to provide necessary direction for a licensed perfusionist in person, by telephone, or by other electronic means.
(8) “Joint Commission” means the organization formerly known as the Joint Commission on the Accreditation of Health Care Organizations.
(9) “License” means a license issued by the Board to practice perfusion.
(10) “Licensed perfusionist” means a perfusionist who is licensed by the Board, in accordance with Health Occupations Article, Title 14, Subtitle 5E, Annotated Code of Maryland, to practice perfusion as a:
(a) Licensed perfusionist-advanced; or
(b) Licensed perfusionist-basic.
(11) “Licensed perfusionist-advanced” means an individual who is licensed by the Board as a perfusionist based on current certification as a certified clinical perfusionist.
(12) “Licensed perfusionist-basic” means an individual who:
(a) Is licensed by the Board as a perfusionist for a limited time based on graduation from an accredited perfusion educational program; and
(b) Has not yet passed the national certifying examinations given by the national certifying board.
(13) “Licensed physician” means a physician licensed by the Board.
(14) “National certifying board” means the American Board of Cardiovascular Perfusion or its successor.
(15) “National certifying examinations” means the two examinations given by the national certifying board.
(16) “On-site direction” means the responsibility of a licensed physician to provide necessary direction for a licensed perfusionist when the physician is:
(a) Physically present in the procedure room or in the facility; and
(b) Able to respond if the perfusionist needs assistance during a procedure.
(17) Practice Perfusion.
(a) “Practice perfusion” means to perform the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems, or other organs to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and the supervision of a licensed physician.
(b) “Practice perfusion” includes:
(i) Cardiopulmonary bypass for adult, pediatric, and neonatal patients;
(ii) Extracorporeal circulatory support for renal, neurological, hepatic, and vascular surgery;
(iii) Extracorporeal resuscitation;
(iv) Extracorporeal circulation for long-term support of failing respiratory or cardiac function;
(v) Extracorporeal membrane oxygenation;
(vi) Extracorporeal carbon dioxide removal;
(vii) Myocardial protection;
(viii) Perfusion-assisted direct coronary artery bypass;
(ix) Hemofiltration and hemodialysis;
(x) Anticoagulation and hemostasis monitoring, analysis, and intervention;
(xi) Thermal regulation;
(xii) Blood gas and blood chemistry monitoring, analysis, and intervention;
(xiii) Physiological monitoring, analysis, and intervention;
(xiv) Administration of blood components and pharmaceuticals;
(xv) Administration of anesthetic agents through a heart lung machine at the direction of an anesthesiologist;
(xvi) Ventricular assist device and mechanical circulatory support management;
(xvii) Intra-aortic balloon counterpulsation;
(xviii) Temporary pacemaker management;
(xix) Periodic flow augmentation therapy;
(xxi) Platelet gel production, autologous hemocyte tissue matrix production;
(xxii) Nondifferentiated progenitor cell harvest bone marrow aspirate concentration;
(xxiii) Acute normovolemic hemodilution;
(xxiv) Isolated limb or organ delivery of chemotherapeutics, progenitor cells, gene therapy vectors, and other items;
(xxv) Organ procurement and preservation;
(xxvi) Thermogenic lavage;
(xxvii) Electrophysiological analysis;
(xxviii) Therapeutic hyperthermia;
(xxix) Intravascular membrane oxygenation; and
(xxx) Renal perfusion.
(18) “Student” means an individual who, in accordance with Health Occupations Article, §14-5E-09(c), Annotated Code of Maryland, is:
(a) Enrolled in an accredited educational program to qualify for a license; and
(b) Performing perfusion services within the accredited program under the supervision of a licensed perfusionist and without compensation.
(19) “Supervision” means the responsibility of a licensed physician to exercise on-site direction or immediately available direction for a licensed perfusionist to ensure the safety and welfare of patients during the course of perfusion.